UK leads Europe in antimicrobial point-of-care diagnostics research

2 July 2015

The UK takes the lead position when it comes to patent filings for point-of-care diagnostics in Europe, according to new research from Landon IP, the patent analytics and consulting arm of intellectual property management specialist CPA Global, and intellectual property firm Marks & Clerk.

The research, a comprehensive patent landscape study undertaken for the Longitude Prize, shows that the UK is second only to the US in the number of first fillings for patent applications directed to point-of-care diagnostics tests since 2009.

After the US (where 258 out of 332 patent families were first filed) and the UK (26 out of 332), Germany, Australia, Singapore and South Korea are the next most common jurisdictions for patent first filings (six each).

The Longitude Prize is a £10 million prize fund aiming to revolutionise global healthcare and conserve antibiotics for future generations. It is run by innovation charity Nesta with the UK's innovation agency, Innovate UK as funding partner.



Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.